Boston Trust Walden Corp Buys 58,687 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Boston Trust Walden Corp increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,437,977 shares of the medical device company's stock after buying an additional 58,687 shares during the period. Cooper Companies comprises approximately 0.9% of Boston Trust Walden Corp's holdings, making the stock its 21st biggest position. Boston Trust Walden Corp owned 0.72% of Cooper Companies worth $121,293,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of COO. Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after buying an additional 2,957,421 shares during the period. Norges Bank acquired a new position in Cooper Companies during the 4th quarter valued at about $217,906,000. FMR LLC grew its position in Cooper Companies by 97.6% in the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $64,826,000. Finally, Victory Capital Management Inc. raised its holdings in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 0.4%

NASDAQ:COO traded up $0.29 during trading hours on Friday, hitting $70.10. 927,217 shares of the company's stock traded hands, compared to its average volume of 1,632,647. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The firm has a market cap of $14.02 billion, a P/E ratio of 34.02, a P/E/G ratio of 1.70 and a beta of 0.98. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The stock's fifty day moving average price is $77.44 and its two-hundred day moving average price is $85.43.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.85 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Citigroup reduced their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Loop Capital set a $100.00 price target on Cooper Companies in a research report on Tuesday. Robert W. Baird lowered their price target on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a report on Friday, May 30th. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday. Finally, Wells Fargo & Company lowered their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus price target of $99.70.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.